Redhill Biopharma Ltd. (RDHL): Price and Financial Metrics


Redhill Biopharma Ltd. (RDHL): $6.78

-0.18 (-2.59%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

RDHL POWR Grades


  • RDHL scores best on the Value dimension, with a Value rank ahead of 71.86% of US stocks.
  • The strongest trend for RDHL is in Growth, which has been heading down over the past 31 weeks.
  • RDHL ranks lowest in Quality; there it ranks in the 2nd percentile.

RDHL Stock Summary

  • RDHL's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of 80.01% of US stocks.
  • Revenue growth over the past 12 months for RedHill Biopharma Ltd comes in at 1,395.15%, a number that bests 99.24% of the US stocks we're tracking.
  • RedHill Biopharma Ltd's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -25.6%, greater than the shareholder yield of merely 10.01% of stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to RedHill Biopharma Ltd are CHNG, CHMA, GLG, XERS, and ADXS.
  • RDHL's SEC filings can be seen here. And to visit RedHill Biopharma Ltd's official web site, go to www.redhillbio.com.

RDHL Stock Price Chart Interactive Chart >

Price chart for RDHL

RDHL Price/Volume Stats

Current price $6.78 52-week high $11.52
Prev. close $6.96 52-week low $5.91
Day low $6.70 Volume 223,170
Day high $7.04 Avg. volume 441,088
50-day MA $6.87 Dividend yield N/A
200-day MA $8.30 Market Cap 314.56M

Redhill Biopharma Ltd. (RDHL) Company Bio


RedHill Biopharma Ltd. focuses on the development and acquisition of late clinical-stage, proprietary, and orally-administered drugs for the treatment of inflammatory and gastrointestinal diseases, including gastrointestinal cancers in Israel. The company was founded in 2009 and is based in Tel Aviv, Israel.


RDHL Latest News Stream


Event/Time News Detail
Loading, please wait...

RDHL Latest Social Stream


Loading social stream, please wait...

View Full RDHL Social Stream

Latest RDHL News From Around the Web

Below are the latest news stories about RedHill Biopharma Ltd that investors may wish to consider to help them evaluate RDHL as an investment opportunity.

Top Pharmaceutical Stocks for Q3 2021

These are the pharmaceutical stocks with the best value, fastest growth, and most momentum for Q3 2021.

Yahoo | June 15, 2021

RedHill Biopharma to Present at the BIO Digital International Convention

RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that Mr. Adi Frish, RedHill's Chief Corporate & Business Development Officer, will present a corporate overview at the BIO Digital International Convention, taking place June 14-18, 2021.

Yahoo | June 9, 2021

RedHill Biopharma Completes Enrollment of Oral Opaganib Phase 2/3 COVID-19 Study

RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it has completed enrollment and randomized the last patient in the global Phase 2/3 study with opaganib (Yeliva®, ABC294640)[1] in patients hospitalized with severe COVID-19 pneumonia (NCT04467840). A total of 475 patients were randomized, more than the planned 464.

Yahoo | June 7, 2021

RedHill EPS beats by $0.29, misses on revenue

RedHill (RDHL): Q1 GAAP EPS of $0.05 beats by $0.29.Revenue of $20.57M (+1840.6% Y/Y) misses by $2.13M.Press Release...

Seeking Alpha | May 27, 2021

35 of the Best Ideas Companies to Present at the Summer Solstice - Best Ideas from the Buy-Side Virtual Investor Conference on June 1-4, 2021

RALEIGH, NC / ACCESSWIRE / May 27, 2021 / The Summer Solstice - Best Ideas from the Buy-Side will take place on June 1-4, 2021, where 35 SmallCap, MicroCap and NanoCap public companies will be presenting via virtual webcast to a global investor audience.The Summer Solstice - Best Ideas from the Buy Side: VIRTUAL begins on Tuesday, June 1, 2021, with company presentations beginning at 9am Eastern Time.

Yahoo | May 27, 2021

Read More 'RDHL' Stories Here

RDHL Price Returns

1-mo 0.44%
3-mo -9.84%
6-mo -20.70%
1-year 2.11%
3-year -14.18%
5-year -32.87%
YTD -16.09%
2020 33.11%
2019 9.37%
2018 7.98%
2017 -50.86%
2016 -18.79%

Continue Researching RDHL

Want to see what other sources are saying about RedHill Biopharma Ltd's financials and stock price? Try the links below:

RedHill Biopharma Ltd (RDHL) Stock Price | Nasdaq
RedHill Biopharma Ltd (RDHL) Stock Quote, History and News - Yahoo Finance
RedHill Biopharma Ltd (RDHL) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 1.0244 seconds.